Paper Title:
Pentose Phosphate Pathway in Disease and Therapy
  Abstract

Pentose phosphate (PP) pathway, which is ubiquitously present in all living organisms, is one of the major metabolic pathways associated with glucose metabolism. The most important functions of this pathway includes the generation of reducing equivalents in the form of NADPH for reductive biosynthesis, and production of ribose sugars for the biosynthesis of nucleotides, amino acids, and other macromolecules required by all living cells. Under normal conditions of growth, PP pathway is important for cell cycle progression, myelin formation, and the maintenance of the structure and function of brain, liver, cortex and other organs. Under diseased conditions, such as in cases of many metabolic, neurological or malignant diseases, pathological mechanisms augment due to defects in the PP pathway genes. Adoption of alternative metabolic pathways by cells that are metabolically abnormal, or malignant cells that are resistant to chemotherapeutic drugs often plays important roles in disease progression and severity. Accordingly, the PP pathway has been suggested to play critical roles in protecting cancer or abnormal cells by providing reduced environment, to protect cells from oxidative damage and generating structural components for nucleic acids biosynthesis. Novel drugs that targets one or more components of the PP pathway could potentially serve to overcome challenges associated with currently available therapeutic options for many metabolic and non-metabolic diseases. However, careful designing of drugs is critical that takes into the accounts of cell’s broader genomic, proteomic and metabolic contexts under consideration, in order to avoid undesirable side-effects. In this review, we discuss the role of PP pathway under normal and abnormal physiological conditions and the potential of the PP pathway as a target for new drug development to treat metabolic and non-metabolic diseases.

  Info
Periodical
Edited by
Mohammad A. Jafar Mazumder and Amir Al-Ahmed
Pages
1-27
DOI
10.4028/www.scientific.net/AMR.995.1
Citation
M. Rahman, M. R. Hasan, "Pentose Phosphate Pathway in Disease and Therapy", Advanced Materials Research, Vol. 995, pp. 1-27, 2014
Online since
July 2014
Export
Price
$35.00
Share
* Corresponding Author

In order to see related information, you need to Login.

In order to see related information, you need to Login.

Authors: Juan Pablo Cárdenas, Verónica Martínez, P. Covarrubias, David S. Holmes, Raquel Quatrini
Abstract:Previous physiological studies of the genus Ferroplasma have indicated that these microorganisms are capable of fixing CO2 in the presence of...
219
Authors: Hui Lan Liu
Abstract:The induction and regulation network of tumor cell apoptosis is built by integrating several seperated pathway of signal transduction and...
1250
Authors: Ning Chen, Yong Feng Qin, Qing Yang Xu, Xi Xian Xie
Chapter 1: Materials Engineering and Industry
Abstract:In this stuty, overexpression of the ilvBN gene, enconding acetohydroxy acid synthase (AHAS), in the valine-prouducing strain Brevibacterium...
160
Authors: Yu Qiao, Xue Jiao Meng, Xiao Xia Jin, Guo Hua Ding
Chapter 1: Chemical Engineering
Abstract:Phenylpropanoid metabolism is an important secondary metabolism pathway in plants. Lignin, as a secondary metabolite was produced by...
53
Authors: Shi Kun Jin, Shou Jing Zhao
Chapter 4: Applied Materials Science and Chemical Engineering, Processing Technologies of Materials and Raw Materials
Abstract:Ginsenosides, the major bioactive ingredients of P. ginseng can improve the anti-disease abilities of human being, and generate...
368